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 Melatonin reduced volume of cerebral infarct induced by photothrombosis in 
wild-type mice, not in Cyclooxygenase-1 gene knockout mice 
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³ The Jockey Club Magnetic Resonance Imaging Engineering Centre, The University of Hong Kong, Hong Kong act—Cyclooxygenase (COX) is crucial in inflammation 
plays important role in cerebral ischemia. Anti-
matory effects of melatonin have been verified in 
ous studies. In this study, cerebral blood flow (CBF) was 
tored during operation, infarct volume (IFV) was 
mined with 5-triphenyltetrazolium chloride (TTC) 
ng and MR image, and neurological functions were 
ated with turn in an alley and fall pole test in both COX-
e knockout and wide-type mice with or without melatonin 
nistration 3 days after photothrombosis. CBF reduction, 
nd neurological deficits were not significantly different in 
-1 wild-type and COX-1 knockout mice. Melatonin (15 
g) intraperitoneal injection decreased the CBF 
tion, IFV and the latency to turn in an alley in COX-1 
type mice, whereas the neuroprotective effect of 
onin was attenuated in COX-1 knockout mice. We 
uded that melatonin reduced susceptibility to 
othrombotic stroke. COX-1 gene knockout does not 
 the susceptibility to cerebral ischemia caused by 
othrombosis. COX-1 plays an important role in the 
way of the protection of melatonin.  
eywords— Cyclooxygenase-1 knockout, cerebral infarct, 
onin, MR image 
I.  INTRODUCTION 
troke is the third leading cause of death and a major 
e of disability, and ischemic stroke is the most 
on type. COX contributes to the delayed ischemic 
ge via inflammation. There are two isoforms: COX-1 
COX-2. COX-1 is constitutively expressed and 
nsible for many physiological functions, however, the 
of COX-1 in cerebral ischemia is not well understood. 
e middle cerebral artery occlusion (MCAO) mouse 
e model, Cheung RT et. al found that susceptibility to 
mia did not alter in COX-1 gene knockout mice [1], 
 Iadecola C showed susceptibility increased in COX-1-
ient mice [2]. Melatonin has been shown to possess 
ed anti-inflammatory [3] and anti-carcinogenic 
rties [4], it can enhance the anti-inflammatory effect of 
elective COX-1 and COX-2 inhibitor indomethacin 
elatonin also reduced volume of cerebral infarction in 
MCAO stroke model [6]. However, the pathway of the 
protective effect of melatonin on cerebral ischemia is 
ell known. In this study, our goal is to test whether 
tonin protects brain after cerebral ischemia via COX-1. 
 
II. METHODOLOGY 
 
 All experiments were conducted according to the 
institutional guidelines with the protocol approved by the 
Committee on the Use of Live Animals in Teaching and 
Research, the University of Hong Kong. Heterozygous 
(COX-1-gene +/-) knockout mice of strain C57/BL were 
established at the National Institute of Environmental Health 
Science, NC [7], and a colony was set up in the Laboratory 
Animal Unit, University of Hong Kong. Mice were kept 
under a diurnal lighting condition (12 h light) with food and 
water provided ad libitum. A standard protocol of 
polymerase chain reaction (PCR) was used to determine the 
COX-1 genotype when the mice were 4 weeks old [1].  
 Induction of focal cerebral ischemia: Rose Bengal was 
injected intravenously before illumination, Photothrombosis 
was induced at 2 mm posterior and 3 mm laterally from 
bregma on the left side with illumination of a cold white 
light for 15 min [8].  
 Determination of cerebral blood flow (CBF) in 
penumbra: A laser Doppler flowmeter was used to monitor 
the regional CBF for 15 min during illumination at 6 mm 
lateral and 2 mm posterior to the bregma on the left side [1]. 
 Drug treatment: Melatonin (15 mg/kg) or its vehicle 
was given via an intraperitoneal injection at 0.5 h before 
stroke, 24 h and 48 h after photothrombosis.  
Neurological function evaluation: Neurological function 
assessment was performed 1 h before photothrombosis and 
72 h after photothrombosis [9].  
 Turning in an alley was used as a measure of 
coordinated muscle control. The experimental animal was 
placed facing the back wall of an alley. The amount of time 
required for the animal to turn around and face the open end 
of the alley was recorded.  
 Locomotor Balance and Coordination was measured by 
fall pole test. The experimental animal was placed at the 
center of a horizontal wooden pole that was elevated 75 cm 
above the substrate. A large pillow was placed under the 
screen. Latency to fall was recorded.  
 Determination of infarct volume: IFV was evaluated at 3 
days or 7 days after photothrombosis immediately following 
the evaluation of neurological function with 2,3,5-
triphenyltetrazolium chloride (TTC) staining from bregma 
3.5 mm to bregma –4.5 mm. The hemispheric volumes and 
total infarction were integrated from the respective 
calibrated area measurements that were obtained from the 
digitized images of the TTC-stained brain slices, using a 
computer-assisted image analysis system. The infarct 
volumes were normalized and expressed as a percentage of 
the ipsilateral hemispheric volume.  
 MR image: The Cerebral infarct volume of formalin-
perfused fixed mice brain was also evaluated with MR 
image. All MR image studies were done in a 1.5 T GE MR 
system at the imaging Center of Hua Qiao Hospital. Infarct 
volume (mm3) was calculated by manually delineating 
hyperintense areas from the T2-weighted imaging by using 
SMIS image software. Results are expressed as lesion 
volume percentage from the volume of the ipsilateral 
hemisphere [10]. 
 
 
III.  RESULTS 
 
 Melatonin (15 mg/kg) decreased the CBF in penumbra 
during operation in wild-type (COX -/-) mice compared 
with vehicle group, while in COX-1 knockout (COX-1 +/- 
or COX-1 +/+) mice, melatonin failed to influent the CBF in 
penumbra (Fig 1). In vehicle groups, there were no 
significant differences in CBF in penumbra among the three 
genotypes groups. 
 As shown in Fig 2, melatonin (15 mg/kg) reduced the 
relative IFV (measure with TTC staining) significantly in 
wild-type (COX-1 -/-) mice 3 days after photothrombosis 
compared with vehicle group. In COX-1 knockout (COX-1 
+/- or COX-1 +/+) mice, melatonin administration did not 
affect IFV significantly. Compared with wild type group, 
the IFV of COX-1 knockout groups did not change in 
vehicle groups. 
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Fig 2. Effect of melatonin on IFV 3 days after 
photothrombosis in the COX-1 wild type (COX-1 -/-
), COX-1 knockout (COX-1 +/- or COX-1 +/+) mice 
with TTC staining (n=6). ** P<0.01, compared with 
vehicle group 
 As shown in Fig 3 (A), IFV in melatonin treated group 
decreased in wild type mice 3 days after photothrombosis. 
In COX-1 knockout mice, IFV was not significant 
difference between melatonin treated and vehicle groups. 
Among three genotypes group, there were no significant 
differences in IFV in vehicle groups. 
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Fig 3. (A) The effect of melatonin on relative cerebral IFV 
3 days after photothrombosis in the COX-1 wild type 
(COX-1 -/-), COX-1 knockout (COX-1 +/- or COX-1 +/+) 
mice (n=6; ** P<0.01) compared with vehicle group. (B) 
MR T2-weighted images taken 3 days after photo-
thrombosis in the COX-1 knockout (COX-1 +/+) mice. 
Fig 1. Effect of melatonin (15 mg/kg) on CBF in 
penumbra in the COX-1 wild type (COX-1 -/-), COX-1 
knockout (COX-1 +/- or COX-1 +/+) mice (n=6). ** 
P<0.01, compared with vehicle group 
 As shown in Fig 4, latency to turn in an alley prolonged 
significantly 3 days after photothrombosis in three genotype 
mice groups (vehicle) compared with sham group. 
Melatonin (15 mg/kg) administration reduced latency to turn 
in an alley in wild-type (COX-1 -/-) mice group compared 
with vehicle group, but in COX-1 knockout (COX-1 +/- or 
COX-1 +/+) mice, melatonin had no any effects. There were 
no differences in latency to fall pole in sham, vehicle and 
treatment groups either in wild type or COX-1 knockout 
mice (data not shown).  
 
Fig 4. Effect of melatonin on latency to turn in an alley 3 
days after photothrombosis in the COX-1 wild-type (COX-
1 -/-), COX-1 knockout (COX-1 +/- or COX-1 +/+) mice 
(n=6). ** P<0.01, compared with sham group; ## P<0.01, 
compared with vehicle group 
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IV.  DISCUSSION 
 
 Inflammation has been considered as one of the most 
important mechanisms upon the damage after ischemia. 
Anti-inflammation has been shown to be the main roles of 
melatonin, which is regard as the mechanism of 
neuroprotection [5]. The neuroprotective effect of melatonin 
has been reported in rat with MCAO model [6]. In the 
present study, the infarct volume decreased after 
administration of melatonin in COX-1 wild-type (COX-1 -/-
) mice with photothrombosis model. Previous study showed 
that melatonin enhanced the effect of indomethacin, a non-
selective COX-1 and COX-2 inhibitor [5], but which 
subtype of COX is involved is still unclear. 
 It is controversial that whether COX-1-gene deficiency 
increases susceptibility to ischemia brain damage in MCAO 
mice model [1, 2]. Our present study demonstrated that 
COX-1-gene knockout did not increase vulnerability to 
cerebral ischemia in CBF, IFV and neurological functions, 
which is consistent with our previous results in MCAO 
model [1].  
 The most important results of the present study is that 
the neuroprotective effect of melatonin attenuated in COX-
1-gene knockout (COX-1 -/+ or COX-1 +/+) mice, 
implicating that COX-1 may play a key role in the signal 
transduction pathway of neuroprotection of melatonin. The 
mechanism need further study. 
 
 
V.  CONCLUSION 
 Melatonin reduces susceptibility to photothrombotic 
stroke with improved neurological functions and decreased 
IFV evaluated with both TTC staining and MR images. 
COX-1 gene knockout does not alter the susceptibility to 
cerebral ischemia caused by photothrombosis. COX-1 plays 
an important role in the pathway of the protection of 
melatonin.  
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